Lincoln Pharmaceuticals Limited

Lincoln Pharmaceuticals Limitedverified

LINCOLN.NS

Price:

$480.9

Market Cap:

$9.63B

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuret...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-12-17

Stock Exchange

NSE

Ticker

LINCOLN.NS

The ROE as of December 2025 (TTM) for Lincoln Pharmaceuticals Limited (LINCOLN.NS) is 11.86%

According to Lincoln Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 11.86%. This represents a change of 299.16% compared to the average of 2.97% of the last 4 quarters.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Historical ROE (quarterly & annually)

How has LINCOLN.NS ROE performed in the past?

The mean historical ROE of Lincoln Pharmaceuticals Limited over the last ten years is 15.70%. The current 11.86% ROE has changed -24.48% with respect to the historical average. Over the past ten years (40 quarters), LINCOLN.NS's ROE was at its highest in in the June 2016 quarter at 7.81%. The ROE was at its lowest in in the March 2017 quarter at 0.66%.

Quarterly (TTM)
Annual

Average

15.70%

Median

15.88%

Minimum

12.26%

Maximum

18.08%

Lincoln Pharmaceuticals Limited (LINCOLN.NS) ROE by Quarter and Year

Discovering the peaks and valleys of Lincoln Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 25.63%

Maximum Annual ROE = 18.08%

Minimum Annual Increase = -22.10%

Minimum Annual ROE = 12.26%

Quarterly (TTM)
Annual
YearROEChange
202512.26%-22.10%
202415.74%8.48%
202314.51%-9.45%
202216.02%-5.70%
202116.99%3.41%
202016.43%-9.15%
201918.08%17.12%
201815.44%5.63%
201714.62%-13.72%
201616.94%25.63%

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Average ROE

How has LINCOLN.NS ROE performed in the past?

The current ROE of Lincoln Pharmaceuticals Limited (LINCOLN.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.17%

5-year avg

15.10%

10-year avg

15.70%

Lincoln Pharmaceuticals Limited (LINCOLN.NS) ROE vs. Peers

How is LINCOLN.NS’s ROE compared to its peers?

Lincoln Pharmaceuticals Limited’s ROE is less than Wanbury Limited (75.83%), less than Wanbury Limited (75.83%), greater than Themis Medicare Limited (-6.76%), greater than Themis Medicare Limited (-6.76%), less than Sakar Healthcare Limited (6.82%), less than Venus Remedies Limited (12.73%), less than Venus Remedies Limited (12.73%), greater than Max India Limited (-36.92%), less than Ind-Swift Laboratories Limited (22.80%), less than Ind-Swift Laboratories Limited (22.80%),

Build a custom stock screener for Lincoln Pharmaceuticals Limited (LINCOLN.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lincoln Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lincoln Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Lincoln Pharmaceuticals Limited's ROE?

How is the ROE calculated for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?

What is the highest ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?

What is the 3-year average ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?

What is the 5-year average ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?

How does the current ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS) compare to its historical average?